Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
CRVS
$14.89
-1.65%
CRVS · Corvus Pharmaceuticals, Inc.
$14.89
-0.25 (-1.65%)
At close · Aug 14
Market Cap
$1.25B
Shares
84.12M
All earnings calls
Earnings call · FY2026 Q2
Corvus Pharmaceuticals, Inc. Q2 FY2026 Earnings Call
Corvus Pharmaceuticals, Inc. Q2 FY2026 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$0.19
Net income
-$17.96M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document